… and infection with extended spectrum beta-lactamase producing Enterobacteriaceae in high-risk patients–Review of the literature from a clinical perspective

LM Biehl, M Schmidt-Hieber, B Liss… - Critical reviews in …, 2016 - Taylor & Francis
Full article: Colonization and infection with extended spectrum beta-lactamase producing
Enterobacteriaceae in high-risk patients – Review of the literature from a clinical perspective

Clinical perspective of antimicrobial resistance in bacteria

Y Zhu, WE Huang, Q Yang - Infection and drug resistance, 2022 - Taylor & Francis
… Citation23 Some special OXA-type β-Lactamase, OXA‐10 and OXA‐13 to OXA‐19, also
hydrolyze extended spectrum cephalosporins and they are also regarded as ESBLs. Citation26 …

[PDF][PDF] Infections Caused by Extended-Spectrum β-lactamase-Producing Enterobacteriaceae: Clinical and Molecular Epidemiology and Treatment Strategies

AT Aslan, M Akova - Infectious Diseases and Clinical Microbiology, 2019 - idcmjournal.org
Extended-spectrum beta-lactamases (ESBLs) are one of the most common defence … In
the early 1980s, broad spectrum-cephalosporins (BSCs) were introduced into clinical practice. …

Extended spectrum β-lactamase producing enterobacteriaceae: carbapenem sparing options

AT Aslan, M Akova - Expert review of anti-infective therapy, 2019 - Taylor & Francis
Extended spectrum beta-lactamase producing gram-negative bacteria are frequent culprits
in different types of infections in clinical practice worldwide. Although the data are limited to …

Efficacy of βlactam/βlactamase inhibitors to treat extendedspectrum betalactamase‐producing Enterobacterales bacteremia secondary to urinary tract infection in …

…, B Gutiérrez‐Gutiérrez… - Transplant Infectious …, 2021 - Wiley Online Library
Background Whether active therapy with β‐lactam/β‐lactamase inhibitors (BLBLI) is as
affective as carbapenems for extendedspectrum β‐lactamase‐producing Enterobacterales (…

[HTML][HTML] From genotype to antibiotic susceptibility phenotype in the order Enterobacterales: a clinical perspective

E Ruppé, A Cherkaoui, Y Charretier, M Girard… - Clinical Microbiology …, 2020 - Elsevier
… From this clinical perspective, we observed very good performances for ceftazidime (in
non-AmpC producing strains), cefepime (all strains), fluoroquinolones and aminoglycosides, with …

The EC-COMPASS: Long-term, multi-centre surveillance of Enterobacter cloacae complex–a clinical perspective

MD Mauritz, B Claus, J Forster, M Petzold… - Journal of Hospital …, 2024 - Elsevier
… EC-COMPASS offers a profound clinical perspective on ECCO infections in German
tertiary-healthcare settings, highlighting elderly men in oncology and intensive care units as …

A clinical perspective on the antimicrobial resistance spectrum of uropathogens in a Romanian male population

…, RC Petca, C Mareș, RI Popescu, B Enikő… - Microorganisms, 2020 - mdpi.com
Considering urinary tract infections (UTIs), a significant public health problem with negligible
recent research, especially on the male eastern European population, we aimed to …

The spectrum of sepsis-associated encephalopathy: a clinical perspective

R Sonneville, S Benghanem, L Jeantin… - Critical Care, 2023 - Springer
Sepsis-associated encephalopathy is a severe neurologic syndrome characterized by a
diffuse dysfunction of the brain caused by sepsis. This review provides a concise overview of …

Machine learning for antimicrobial resistance prediction: current practice, limitations, and clinical perspective

JI Kim, F Maguire, KK Tsang, T Gouliouris… - Clinical microbiology …, 2022 - Am Soc Microbiol
Antimicrobial resistance (AMR) is a global health crisis that poses a great threat to modern
medicine. Effective prevention strategies are urgently required to slow the emergence and …